Is PHIOW or DIVO a better dividend investment in 2026?

PHIOW currently yields 8620.69% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: PHIOW offers higher current income.

What is the dividend yield difference between PHIOW and DIVO?

PHIOW has a forward dividend yield of 8620.69% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 8614.07 percentage points.

Home › Compare › PHIOW vs DIVO

PHIOW vs DIVO: Dividend Comparison 2026

PHIOW yields 8620.69% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PHIOW wins by $12793007580007856.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PHIOW

● Live price

8620.69%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$12793007580007856.00M

Annual income

$12,507,597,271,400,990,000,000.00

Full PHIOW calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — PHIOW vs DIVO

📍 PHIOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PHIOW	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PHIOW + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PHIOW pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHIOW

Annual income on $10K today (after 15% tax)

$732,758.62/yr

After 10yr DRIP, annual income (after tax)

$10,631,457,680,690,841,000,000.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, PHIOW beats the other by $10,631,457,680,690,841,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHIOW + DIVO for your $10,000?

PHIOW: 50%DIVO: 50%

100% DIVO50/50100% PHIOW

Portfolio after 10yr

$6396503790003928.00M

Annual income

$6,253,798,635,700,495,000,000.00/yr

Blended yield

97.77%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHIOW buys

DIVO buys

No recent congressional trades found for PHIOW or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPHIOWDIVO

Forward yield	8620.69% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$12793007580007856.00M ✓	$31.0K
Annual income after 10y	$12,507,597,271,400,990,000,000.00 ✓	$1,008.47
Total dividends collected	$12773964733154094.00M ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: PHIOW vs DIVO ($10,000, DRIP)

Year	PHIOW Portfolio	PHIOW Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$872,769	$862,068.97	$11,362	$661.96	+$861.4K → PHIOW
2	$71,250,409	$70,316,545.72	$12,860	$702.91	+$71.24M → PHIOW
3	$5,441,140,196	$5,364,902,258.92	$14,504	$743.56	+$5441.13M → PHIOW
4	$388,717,812,241	$382,895,792,231.73	$16,303	$783.73	+$388717.80M → PHIOW
5	$25,980,665,800,186	$25,564,737,741,087.56	$18,268	$823.31	+$25980665.78M → PHIOW
6	$1,624,683,420,105,904	$1,596,884,107,699,705.00	$20,408	$862.17	+$1624683420.09M → PHIOW
7	$95,065,580,496,684,460	$93,327,169,237,171,150.00	$22,737	$900.20	+$95065580496.66M → PHIOW
8	$5,205,346,525,995,166,000	$5,103,626,354,863,713,000.00	$25,266	$937.31	+$5205346525995.14M → PHIOW
9	$266,738,606,174,640,700,000	$261,168,885,391,825,900,000.00	$28,008	$973.42	+$266738606174640.66M → PHIOW
10	$12,793,007,580,007,855,000,000	$12,507,597,271,400,990,000,000.00	$30,977	$1,008.47	+$12793007580007856.00M → PHIOW

PHIOW vs DIVO: Complete Analysis 2026

PHIOW — Stock

Phio Pharmaceuticals Corp., a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762 which targets the checkpoint protein PD-1 on immune cells for used in adoptive cell transfer (ACT); PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for used in ACT; and PH-790 which targets PD-L1 protein that keeps immune cells from attacking nonharmful cells in the body. It has collaborations with the Gustave Roussy and Medigene AG, as well as with Helmholtz Zentrum München. Phio Pharmaceuticals has collaboration with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Full PHIOW Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this PHIOW vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHIOW vs SCHD PHIOW vs JEPI PHIOW vs O PHIOW vs KO PHIOW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.